• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抑制T细胞增殖和细胞毒性功能的CD8 + CD28 - 调节性淋巴细胞浸润人类癌症。

CD8+ CD28- T regulatory lymphocytes inhibiting T cell proliferative and cytotoxic functions infiltrate human cancers.

作者信息

Filaci Gilberto, Fenoglio Daniela, Fravega Marco, Ansaldo Gianluca, Borgonovo Giacomo, Traverso Paolo, Villaggio Barbara, Ferrera Alessandra, Kunkl Annalisa, Rizzi Marta, Ferrera Francesca, Balestra Piercesare, Ghio Massimo, Contini Paola, Setti Maurizio, Olive Daniel, Azzarone Bruno, Carmignani Giorgio, Ravetti Jean Louis, Torre Giancarlo, Indiveri Francesco

机构信息

Centre of Excellence for Biomedical Research, University of Genoa, Genoa, Italy.

出版信息

J Immunol. 2007 Oct 1;179(7):4323-34. doi: 10.4049/jimmunol.179.7.4323.

DOI:10.4049/jimmunol.179.7.4323
PMID:17878327
Abstract

Tumor growth is allowed by its ability to escape immune system surveillance. An important role in determining tumor evasion from immune control might be played by tumor-infiltrating regulatory lymphocytes. This study was aimed at characterizing phenotype and function of CD8+ CD28- T regulatory cells infiltrating human cancer. Lymphocytes infiltrating primitive tumor lesion and/or satellite lymph node from a series of 42 human cancers were phenotypically studied and functionally analyzed by suppressor assays. The unprecedented observation was made that CD8+ CD28- T regulatory lymphocytes are almost constantly present and functional in human tumors, being able to inhibit both T cell proliferation and cytotoxicity. CD4+ CD25+ T regulatory lymphocytes associate with CD8+ CD28- T regulatory cells so that the immunosuppressive activity of tumor-infiltrating regulatory T cell subsets, altogether considered, may become predominant. The infiltration of regulatory T cells seems tumor related, being present in metastatic but not in metastasis-free satellite lymph nodes; it likely depends on both in situ generation (via cytokine production) and recruitment from the periphery (via chemokine secretion). Collectively, these results have pathogenic relevance and implication for immunotherapy of cancer.

摘要

肿瘤能够逃避免疫系统的监视,从而得以生长。肿瘤浸润性调节淋巴细胞在决定肿瘤逃避免疫控制方面可能发挥重要作用。本研究旨在表征浸润人类癌症的CD8+ CD28-调节性T细胞的表型和功能。对来自42例人类癌症的原发性肿瘤病灶和/或卫星淋巴结中的浸润淋巴细胞进行了表型研究,并通过抑制试验进行了功能分析。有一个前所未有的发现,即CD8+ CD28-调节性淋巴细胞几乎始终存在于人类肿瘤中并发挥功能,能够抑制T细胞增殖和细胞毒性。CD4+ CD25+调节性淋巴细胞与CD8+ CD28-调节性细胞相关联,因此,总体而言,肿瘤浸润性调节性T细胞亚群的免疫抑制活性可能占主导地位。调节性T细胞的浸润似乎与肿瘤相关,存在于转移性卫星淋巴结中,而不存在于无转移的卫星淋巴结中;它可能既依赖于原位生成(通过细胞因子产生),也依赖于从外周募集(通过趋化因子分泌)。总的来说,这些结果对癌症免疫治疗具有致病相关性和启示意义。

相似文献

1
CD8+ CD28- T regulatory lymphocytes inhibiting T cell proliferative and cytotoxic functions infiltrate human cancers.抑制T细胞增殖和细胞毒性功能的CD8 + CD28 - 调节性淋巴细胞浸润人类癌症。
J Immunol. 2007 Oct 1;179(7):4323-34. doi: 10.4049/jimmunol.179.7.4323.
2
Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function.非抗原特异性CD8 + T抑制淋巴细胞起源于CD8 + CD28 - T细胞,并抑制T细胞增殖和CTL功能。
Hum Immunol. 2004 Feb;65(2):142-56. doi: 10.1016/j.humimm.2003.12.001.
3
Lack of terminally differentiated tumor-specific CD8+ T cells at tumor site in spite of antitumor immunity to self-antigens in human metastatic melanoma.尽管人类转移性黑色素瘤对自身抗原有抗肿瘤免疫,但肿瘤部位缺乏终末分化的肿瘤特异性CD8 + T细胞。
Cancer Res. 2003 May 15;63(10):2535-45.
4
Advancements on phenotypic and functional characterization of non-antigen-specific CD8+CD28- regulatory T cells.非抗原特异性CD8+CD28-调节性T细胞表型和功能特征的研究进展
Hum Immunol. 2008 Nov;69(11):745-50. doi: 10.1016/j.humimm.2008.08.282. Epub 2008 Sep 29.
5
Follicular lymphoma intratumoral CD4+CD25+GITR+ regulatory T cells potently suppress CD3/CD28-costimulated autologous and allogeneic CD8+CD25- and CD4+CD25- T cells.滤泡性淋巴瘤瘤内CD4+CD25+GITR+调节性T细胞可有效抑制经CD3/CD28共刺激的自体和同种异体CD8+CD25-及CD4+CD25-T细胞。
J Immunol. 2007 Apr 1;178(7):4051-61. doi: 10.4049/jimmunol.178.7.4051.
6
Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer.早期非小细胞肺癌和晚期卵巢癌患者肿瘤中的调节性CD4(+)CD25(+) T细胞
Cancer Res. 2001 Jun 15;61(12):4766-72.
7
IL-10 inducible CD8 regulatory T-cells are enriched in patients with multiple myeloma and impact the generation of antigen-specific T-cells.白细胞介素-10 诱导的 CD8 调节性 T 细胞在多发性骨髓瘤患者中富集,并影响抗原特异性 T 细胞的产生。
Cancer Immunol Immunother. 2018 Nov;67(11):1695-1707. doi: 10.1007/s00262-018-2230-0. Epub 2018 Aug 20.
8
CD11b expression identifies CD8+CD28+ T lymphocytes with phenotype and function of both naive/memory and effector cells.CD11b表达可识别出具有初始/记忆细胞和效应细胞表型及功能的CD8⁺CD28⁺ T淋巴细胞。
J Immunol. 2001 Jan 15;166(2):900-7. doi: 10.4049/jimmunol.166.2.900.
9
Increased cytolytic T lymphocyte activity and decreased B7 responsiveness are associated with CD28 down-regulation on CD8+ T cells from HIV-infected subjects.细胞溶解性T淋巴细胞活性增加和B7反应性降低与HIV感染受试者CD8 + T细胞上CD28下调有关。
Clin Exp Immunol. 1995 Jun;100(3):425-33. doi: 10.1111/j.1365-2249.1995.tb03717.x.
10
Discrepant Clinical Significance of CD28CD8 and CD4CD25 Regulatory T Cells During the Progression of Hepatitis B Virus Infection.乙型肝炎病毒感染进展过程中CD28⁺CD8⁺和CD4⁺CD25⁺调节性T细胞的临床意义差异
Viral Immunol. 2018 Oct;31(8):548-558. doi: 10.1089/vim.2018.0035. Epub 2018 Aug 17.

引用本文的文献

1
Regulatory T cells in solid tumor immunotherapy: effect, mechanism and clinical application.实体瘤免疫治疗中的调节性T细胞:作用、机制及临床应用
Cell Death Dis. 2025 Apr 11;16(1):277. doi: 10.1038/s41419-025-07544-w.
2
Genetically Predicted Immune Cell Traits Mediate the Causal Association Between Plasma Metabolites and Colorectal Cancer.基因预测的免疫细胞特征介导血浆代谢物与结直肠癌之间的因果关联。
J Cancer. 2025 Jan 1;16(2):430-444. doi: 10.7150/jca.101011. eCollection 2025.
3
Immunosenescence and age-related immune cells: causes of age-related diseases.
免疫衰老与年龄相关的免疫细胞:与年龄相关疾病的成因
Arch Pharm Res. 2025 Feb;48(2):132-149. doi: 10.1007/s12272-024-01529-7. Epub 2024 Dec 26.
4
Circulating tumor-reactive KIRCD8 T cells suppress anti-tumor immunity in patients with melanoma.循环肿瘤反应性KIR⁺ CD8⁺ T细胞抑制黑色素瘤患者的抗肿瘤免疫。
Nat Immunol. 2025 Jan;26(1):82-91. doi: 10.1038/s41590-024-02023-4. Epub 2024 Nov 28.
5
CD28 co-stimulation: novel insights and applications in cancer immunotherapy.CD28 共刺激:癌症免疫治疗的新见解和应用。
Nat Rev Immunol. 2024 Dec;24(12):878-895. doi: 10.1038/s41577-024-01061-1. Epub 2024 Jul 25.
6
Peripheral Blood CD8 CD28 T Cells as an Independent Predictor of Treatment Response and Survival After Concurrent Chemoradiotherapy in Pediatric High-Grade Glioma Patients.外周血CD8 CD28 T细胞作为小儿高级别胶质瘤患者同步放化疗后治疗反应和生存的独立预测指标
Clin Med Insights Oncol. 2024 Feb 5;18:11795549241227421. doi: 10.1177/11795549241227421. eCollection 2024.
7
Learning from the nexus of autoimmunity and cancer.从自身免疫与癌症的联系中学习。
Immunity. 2023 Feb 14;56(2):256-271. doi: 10.1016/j.immuni.2023.01.022.
8
CD4CD25 T regulatory cells in renal transplantation.肾移植中的 CD4CD25T 调节性细胞。
Front Immunol. 2022 Nov 8;13:1017683. doi: 10.3389/fimmu.2022.1017683. eCollection 2022.
9
Circulating CD8CD122 T cells as a prognostic indicator of pancreatic cancer.循环 CD8CD122 T 细胞作为胰腺癌的预后指标。
BMC Cancer. 2022 Nov 4;22(1):1134. doi: 10.1186/s12885-022-10207-0.
10
CD8 T regulatory cells in lupus.狼疮中的CD8调节性T细胞。
Rheumatol Immunol Res. 2021 Dec 15;2(3):147-156. doi: 10.2478/rir-2021-0021. eCollection 2021 Sep 1.